Human Growth Hormone (HGH) vs IGF-1 LR3 vs Tesamorelin
A three-way comparison to help you find the right peptide for your research goals.
Human Growth Hormone (HGH)
Human Growth Hormone (somatropin) is a 191-amino acid protein identical to naturally produced GH. FDA-approved for growth hormone deficiency, Turner syndrome, and other conditions. Widely used off-label for anti-aging and performance.
Full details →IGF-1 LR3
IGF-1 LR3 (Long R3 Insulin-like Growth Factor-1) is a modified version of IGF-1 with extended half-life and enhanced potency. The modifications prevent binding to IGF binding proteins, increasing bioavailability.
Full details →Tesamorelin
Tesamorelin is a synthetic analog of growth hormone-releasing hormone (GHRH). It is FDA-approved under the brand name Egrifta for reducing excess abdominal fat in HIV-infected patients with lipodystrophy.
Full details →Side-by-Side Comparison
| Aspect | Human Growth Hormone (HGH) | IGF-1 LR3 | Tesamorelin |
|---|---|---|---|
| Mechanism | Binds to GH receptors throughout the body, stimulating IGF-1 production in the liver. Promotes protein synthesis, fat metabolism, and cellular regeneration across multiple tissues. | Binds to IGF-1 receptors to promote protein synthesis, muscle growth, and fat metabolism. The LR3 modification (13 amino acid extension and arginine substitution) extends half-life from minutes to 20-30 hours. | Stimulates the pituitary gland to produce and release growth hormone by binding to GHRH receptors. Increases IGF-1 levels which promotes lipolysis and reduces visceral adipose tissue. |
| Typical Dosage | Medical: 0.1-0.3mg/kg/week divided into daily doses. Anti-aging: 1-2 IU daily. Performance: 2-6 IU daily, sometimes higher. | Research protocols typically use 20-100mcg daily, often divided into multiple injections or administered bilaterally to target muscles. | FDA-approved dose: 2mg administered subcutaneously once daily. Research protocols may use various dosing schedules. |
| Administration | Subcutaneous injection, preferably at night to mimic natural pulsatile release. Rotate injection sites. Store refrigerated. | Intramuscular injection (site-specific growth) or subcutaneous for systemic effects. Often cycled 4-6 weeks on, equal time off. | Subcutaneous injection into the abdomen. Rotate injection sites. Best administered at the same time daily, preferably in the evening. |
| Side Effects | Joint pain, water retention, carpal tunnel syndrome, potential insulin resistance, and acromegaly features with long-term high doses. | Hypoglycemia, joint pain, water retention, potential jaw/hand growth with extended use, and injection site reactions. | Common side effects include injection site reactions (erythema, pruritus), joint pain, peripheral edema, and muscle pain. May cause elevated blood glucose. |
| Best For |
What They Have in Common
Human Growth Hormone (HGH), IGF-1 LR3, Tesamorelin are all commonly used for:
Key Differences
Unique to Human Growth Hormone (HGH):
Unique to IGF-1 LR3:
Detailed Analysis
Commonalities
Both Human Growth Hormone (HGH) and IGF-1 LR3 are commonly used for Muscle Growth, Fat Loss, Recovery & Healing.
Which Should You Choose?
Human Growth Hormone (HGH) has stronger evidence for Fat Loss, Recovery & Healing.
Commonalities
Both Human Growth Hormone (HGH) and Tesamorelin are commonly used for Muscle Growth, Fat Loss.
Which Should You Choose?
Human Growth Hormone (HGH) has stronger evidence for Muscle Growth.
Commonalities
Both IGF-1 LR3 and Tesamorelin are commonly used for Muscle Growth, Fat Loss.
Which Should You Choose?
IGF-1 LR3 has stronger evidence for Muscle Growth. Tesamorelin has stronger evidence for Fat Loss.